The EU drugs agency in Lisbon, as part of its ongoing commitment to strengthening cooperation and sharing expertise, has developed the EU4Monitoring Drugs (EU4MD) project. Funded by the European Union, the project will run from 2019 until the end of 2021 and will involve countries in the European Neighbourhood Policy (ENP) area. It will support national and regional readiness to identify and respond to drug-related security and health threats.